The rational design of cervical cancer prevention strategies

Lancet. 2024 Aug 3;404(10451):406-407. doi: 10.1016/S0140-6736(24)01547-2.

Authors

Mark Schiffman¹, Silvia de Sanjose²

Affiliations

¹ Clinical Epidemiology Unit, Clinical Genetics Branch, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA. Electronic address: schiffmm@exchange.nih.gov.
² National Cancer Institute, Rockville, MD, USA; ISGlobal, Barcelona, Spain.

PMID: 39097380
DOI: 10.1016/S0140-6736(24)01547-2

No abstract available

MeSH terms

Female
Humans
Papillomavirus Infections* / complications
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines* / administration & dosage
Uterine Cervical Neoplasms* / prevention & control

Substances

Papillomavirus Vaccines